Does REPOTRECTINIB Cause Off label use? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Off label use have been filed in association with REPOTRECTINIB (Augtyro). This represents 5.4% of all adverse event reports for REPOTRECTINIB.
10
Reports of Off label use with REPOTRECTINIB
5.4%
of all REPOTRECTINIB reports
1
Deaths
2
Hospitalizations
How Dangerous Is Off label use From REPOTRECTINIB?
Of the 10 reports, 1 (10.0%) resulted in death, 2 (20.0%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REPOTRECTINIB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does REPOTRECTINIB Cause?
Dizziness (32)
Death (21)
Nausea (12)
Adverse event (11)
Neuropathy peripheral (11)
Paraesthesia (10)
Balance disorder (9)
Pain (9)
Hospitalisation (8)
Muscular weakness (8)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which REPOTRECTINIB Alternatives Have Lower Off label use Risk?
REPOTRECTINIB vs REQUIP
REPOTRECTINIB vs RESLIZUMAB
REPOTRECTINIB vs RESMETIROM
REPOTRECTINIB vs RESTASIS
REPOTRECTINIB vs RETINOL